Work

Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1

Year: 2015

Type: article

Source: Virology

DOI: 10.1016/j.virol.2015.06.014

Authors: Erez Pery, Ann Sheehy, N. Miranda Nebane, Vikas Misra, Marie K. Mankowski, Lynn Rasmussen, E. Lucile White, Roger G. Ptak, Dana Gabuzda

Institutions: Harvard University, Dana-Farber Cancer Institute, College of the Holy Cross, Southern Research Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: HIV Research and Treatment

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Health and Human Services, National Institutes of Health, U.S. Public Health Service, National Cancer Institute, National Institute of Allergy and Infectious Diseases

OpenAlex ID: W766117117

FWCI: 0.673

Cites: 89

Cited by: 19

Related to: 10